Patients who received synthetic mesh, which costs about 0.5% of a similarly sized piece of biologic mesh, had comparable outcomes after parastomal hernia repair to patients who received biologic mesh, according to a post hoc analysis of a multicenter randomized trial (J Am Coll Surg 2022;235[3]:401-409).
The analysis showed that, among 108 patients included in the trial who underwent open parastomal hernia repair, there were no differences in wound morbidity, reoperations,